NANOG Is a Direct Target of TGFβ/Activin-Mediated SMAD Signaling in Human ESCs-Reference-Cited by-同舟云学术

NANOG Is a Direct Target of TGFβ/Activin-Mediated SMAD Signaling in Human ESCs

Published:2008-08 Issue:2 Volume:3 Page:196-206
ISSN:1934-5909
Container-title:Cell Stem Cell
language:en
Short-container-title:Cell Stem Cell

Author:

Xu Ren-He,Sampsell-Barron Tori L.,Gu Feng,Root Sierra,Peck Ruthann M.,Pan Guangjin,Yu Junying,Antosiewicz-Bourget Jessica,Tian Shulan,Stewart Ron,Thomson James A.

Publisher

Elsevier BV

Subject

Cell Biology,Genetics,Molecular Medicine

Reference42 articles.

1. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture;Amit;Dev. Biol.,2000

2. Feeder layer- and serum-free culture of human embryonic stem cells;Amit;Biol. Reprod.,2004

3. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers;Beattie;Stem Cells,2005

4. Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3;Besser;J. Biol. Chem.,2004

5. Core transcriptional regulatory circuitry in human embryonic stem cells;Boyer;Cell,2005

Cited by 426 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knocking down RAD51AP1 enhances chemosensitivity by inhibiting the self-renewal of CD133 positive ovarian cancer stem-like cells;Discover Oncology;2024-09-05

2. Inhibition of BMP-mediated SMAD pathway supports the pluripotency of pig embryonic stem cells in the absence of feeder cells;Theriogenology;2024-09

3. Discovering genes and microRNAs involved in human lung development unveils IGFBP3/miR-34a dynamics and their relevance for alveolar differentiation;Stem Cell Research & Therapy;2024-08-26

4. Neuronal Cell Differentiation of iPSCs for the Clinical Treatment of Neurological Diseases;Biomedicines;2024-06-18

5. Establishing stable and highly osteogenic hiPSC-derived MSCs for 3D-printed bone graft through microenvironment modulation by CHIR99021-treated osteocytes;Materials Today Bio;2024-06